Last data update: May 13, 2024 . (Total: 1930 publications since 2020)
Records 1-4 (of 4 Records) |
Query Trace: Sambhara S[original query] |
---|
Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections.
Elkashif A , Alhashimi M , Sayedahmed EE , Sambhara S , Mittal SK . Clin Transl Immunology 2021 10 (10) e1345 |
Innate lymphoid cells (ILC) in SARS-CoV-2 infection.
Kumar A , Cao W , Endrias K , Kuchipudi SV , Mittal SK , Sambhara S . Mol Aspects Med 2021 80 101008 |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
Voss WN , Hou YJ , Johnson NV , Delidakis G , Kim JE , Javanmardi K , Horton AP , Bartzoka F , Paresi CJ , Tanno Y , Chou CW , Abbasi SA , Pickens W , George K , Boutz DR , Towers DM , McDaniel JR , Billick D , Goike J , Rowe L , Batra D , Pohl J , Lee J , Gangappa S , Sambhara S , Gadush M , Wang N , Person MD , Iverson BL , Gollihar JD , Dye J , Herbert A , Finkelstein IJ , Baric RS , McLellan JS , Georgiou G , Lavinder JJ , Ippolito GC . Science 2021 372 (6546) 1108-1112 |
SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination.
Huang WC , Zhou S , He X , Chiem K , Mabrouk MT , Nissly RH , Bird IM , Strauss M , Sambhara S , Ortega J , Wohlfert EA , Martinez-Sobrido L , Kuchipudi SV , Davidson BA , Lovell JF . Adv Mater 2020 32 (50) e2005637 |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure